Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients (Q30485251)

17 August 2017

Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients (English)

1 reference

17 August 2017

1 reference

1 reference

16

Robert L Vessella

1 reference

17 August 2017

12

Lawrence D True

1 reference

17 August 2017

9

Peter S Nelson

1 reference

17 August 2017

Ilona N Holcomb

1

1 reference

17 August 2017

Douglas I Grove

2

1 reference

17 August 2017

Martin Kinnunen

3

1 reference

17 August 2017

Cynthia L Friedman

4

1 reference

17 August 2017

Ian S Gallaher

5

1 reference

17 August 2017

Todd M Morgan

6

1 reference

17 August 2017

Cassandra L Sather

7

1 reference

17 August 2017

Jeffrey J Delrow

8

1 reference

17 August 2017

Paul H Lange

10

1 reference

17 August 2017

William J Ellis

11

1 reference

17 August 2017

Janet M Young

13

1 reference

17 August 2017

Li Hsu

14

1 reference

17 August 2017

Barbara J Trask

15

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

17 August 2017

1 reference

17 August 2017

68

1 reference

17 August 2017

14

1 reference

17 August 2017

5599-5608

1 reference

Models, mechanisms and clinical evidence for cancer dormancy

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

WWOX, a new potential tumor suppressor gene.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Using GOstats to test gene lists for GO term association

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Dissecting the metastatic cascade

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Molecular characterization of human prostate carcinoma cell lines

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

High-resolution genomic profiling of occult micrometastatic tumor cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Genetic alterations in human prostate cancer: a review of current literature.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

20 June 2018

Cancer statistics, 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Natural history of progression after PSA elevation following radical prostatectomy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Genetic alterations in hormone-refractory recurrent prostate carcinomas

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Cadherins in cancer: implications for invasion and metastasis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Tumor cell dormancy: an NCI workshop report

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Gain in chromosome 8q correlates with early progression in hormonal treated prostate cancer.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613025

Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators

26 November 2018

1 reference

12 December 2020

Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics

1 reference

12 December 2020

Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization

1 reference

12 December 2020

Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer

1 reference

12 December 2020

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

12 December 2020

The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer

1 reference

12 December 2020

Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer

1 reference

12 December 2020

Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications

1 reference

12 December 2020

Circulating tumor cells predict survival in patients with metastatic prostate cancer

1 reference

12 December 2020

Genetic aberrations in prostate cancer by microarray analysis

1 reference

12 December 2020

Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy

1 reference

12 December 2020

The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer

1 reference

12 December 2020

Micrometastases of bone marrow in localized prostate cancer: correlation with established risk factors

1 reference

12 December 2020

Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer

1 reference

12 December 2020

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

1 reference

12 December 2020

The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer

1 reference

12 December 2020

Detection and isolation of prostate cancer cells from peripheral blood and bone marrow

1 reference

12 December 2020

10.1158/0008-5472.CAN-08-0812

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18632612

1 reference